Already a Bloomberg.com user?
Sign in with the same account.
Don't have an account?
Help! I can't access my account.
Q: How about Johnson & Johnson (JNJ )?A: We like Johnson & Johnson at current levels. They have a great track record of growing sales and earnings at double-digit rates. The stock didn't participate in last year's rally. Negative news on their drug
Max 250 characters
©2013 Bloomberg L.P. All Rights Reserved. Made in NYC